StockNews.AISignal intelligence

Public signal · 1-minute delayed

Signal brief

Source-backed market context you can read and share without an account.

IBMBullishEarningsnews
High materiality8/10

IBM lifts Q3 results; boosts free cash flow outlook; buys HRL Laboratories

Oct 21, 2026, 4:33 PM EDT2 sourcesAI-analyzed
Why it may matterVerify against the original reporting

Strong Q3 beat and higher FCF guidance typically support stock upside; AI-focused strategy and the HRL acquisition may improve TAM and cash flow visibility, potentially expanding multiples, though execution risk exists if FCF targets lag.

AI summary

What happened, with direct paths to the underlying reporting

IBM beat Q3 estimates with adjusted EPS of $2.95 on $17.10 billion in revenue, led by software strength while consulting stayed flat. Management raised full-year free cash flow guidance by more than $1 billion and kept 2026 revenue growth guidance at 4-5% in constant currency. The company also announced the acquisition of HRL Laboratories from Boeing and GM, signaling a deeper push into AI and R&D capabilities that could support higher-value services over time.

  • IBM Q3 adjusted EPS $2.95 on $17.10B revenue; beat estimates.
  • Free cash flow guidance raised by >$1B; 2026 revenue growth 4-5% CC.
  • IBM to acquire HRL Laboratories from Boeing and GM; price undisclosed.
  • Software revenue $7.80B, up 8% y/y; consulting revenue flat.
  • Stock down ~15% YTD; after-hours rally suggests near-term upside.

How to read this signal

Transparent limits for an AI-generated research aid

StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.